ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.76
0.43%
Dow Jones
42,313.00
0.33%
Gold vs US Dollar
2,652.28
-0.76%
Brent Oil
71.95
1.41%
Bitcoin
65,798.66
0.94%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
27/09/202421:35PR Newswire (US)AT&T Declares Dividends on Common and Preferred SharesNYSE:TAT&T Inc
27/09/202421:35PR Newswire (US)Kratos Capital Announces Acquisition of Weldon Services by Upchurch Services, LLC
27/09/202421:32PR Newswire (US)DonutNV Launches "Sleigh The Holiday" Giveaway for Corporate Events
27/09/202421:30UK RegulatoryLes Données de l'Étude Pivot DREAM Présentées lors de l'International Surgical Sleep Society 2024 Educational UpdateEU:NYXHNyxoah SA
27/09/202421:30UK RegulatoryDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateEU:NYXHNyxoah SA
27/09/202421:30PR Newswire (US)Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma PatientsNASDAQ:PSTXPoseida Therapeutics Inc
27/09/202421:30PR Newswire (US)USCF ANNOUNCES CHANGES TO PRODUCT LINE
27/09/202421:30PR Newswire (US)FHU President David R. Shannon Appoints Dr. LeAnn Davis as Freed-Hardeman University Vice President for Academics
27/09/202421:30PR Newswire (US)Passion 4 Health Introduces Revolutionary Eye Care Supplement for National Eye Health Week
27/09/202421:30PR Newswire (US)CARVYKTI® is the first and only cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second lineNYSE:JNJJohnson and Johnson
27/09/202421:27IH Market NewsDow Reaches Record Closing High But Nasdaq, S&P 500 Give Back GroundCOMPNASDAQ Composite Index
27/09/202421:27IH Market NewsDow Reaches Record Closing High But Nasdaq, S&P 500 Give Back GroundSPI:SP500S&P 500
27/09/202421:17PR Newswire (US)FDA Roundup: September 27, 2024
27/09/202421:16PR Newswire (US)SIGMA LITHIUM HOSTED 2024 INVESTOR DAY, DETAILING A LOW CAPEX CONSTRUCTION PLAN TO TRIPLE CAPACITY TO 125,000t LCE BY END-2026; RECOGNIZED AS CLIMATE PIONEER BY NASDAQNASDAQ:SGMLSigma Lithium Corporation
27/09/202421:06PR Newswire (US)ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS THIRD QUARTER EARNINGSNYSE:AFBAllianceBernstein National Municipal Income Fund Inc
27/09/202421:05PR Newswire (US)Chanson International Holding Announces First Half of Fiscal Year 2024 Financial ResultsNASDAQ:CHSNChanson International Holding
27/09/202421:05PR Newswire (US)TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TMDXTransMedics Group Inc
27/09/202421:00UK RegulatoryOrange press release: Transactions carried out as part of a share buyback program and outside of a liquidity contractTG:FTEOrange.
27/09/202421:00UK RegulatoryOrange press release: Transactions carried out as part of a share buyback program and outside of a liquidity contractEU:ORAOrange.
27/09/202421:00UK RegulatoryOrange communiqué : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéEU:ORAOrange.
27/09/202421:00UK RegulatoryOrange press release: Transactions carried out as part of a share buyback program and outside of a liquidity contractBIT:ORAOrange.
27/09/202421:00UK RegulatoryOrange communiqué : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéBIT:ORAOrange.
27/09/202421:00UK RegulatoryOrange communiqué : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéTG:FTEOrange.
27/09/202421:00UK RegulatoryOrange press release: Transactions carried out as part of a share buyback program and outside of a liquidity contractBIT:1ORAOrange.
27/09/202421:00UK RegulatoryOrange communiqué : Information sur les opérations effectuées dans le cadre d’un programme de rachat d’actions, hors contrat de liquiditéBIT:1ORAOrange.
27/09/202421:00PR Newswire (US)"The Reckoning of Third-Party Risk Management" presented by Lori Frank, President and CEO, at UMACHA's Navigating Payments Conference
27/09/202420:56Alliance NewsAlliance NewsJury out on whether UK will honour Good Friday agreement – O'Neill
27/09/202420:55Alliance NewsAlliance NewsTrump and Zelensky make nice after tensions over Ukraine war
27/09/202420:55PR Newswire (US)Get Fall-Ready with LA LA LEAF's Pumpkin Pie Lip Balm: The Ultimate Autumn Beauty Essential
27/09/202420:54Alliance NewsAlliance NewsChina, Brazil urge against nuclear threats over Ukraine

Your Recent History

NASDAQ
FANH
Fanhua
BIT
UB2RQZ
UniCredit Bank
LSE
39XK
Gran.04 2 1a1
LSE
AK04
Hsbc Bk.27
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved